Cytokines: clues to the pathogenesis of SLE

Linker-Israeli M . Cytokine abnormalities in human lupus . Clin Immunol Immunopathol 1992; 63: 10–12 .

Handwerger BS , Rus V , da Silva L , Via CS . The role of cytokines in the immunopathogenesis of lupus . Springer Semin Immunopathol 1994; 16: 153–180 .

Horwitz DA , Jacob CO . The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications . Springer Semin Immunopathol 1994; 16: 181–200 .

Alcocer-Varela J , Alarcon-Segovia D . Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus . J Clin Invest 1982; 69: 1388–1392 .

Horwitz DA , Garrett MA . Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma . Clin Exp Immunol 1997; 27: 92–99 .

Crispin JC , Alcocer-Varela J . Interleukin-2 and systemic lupus erythematosus. Fifteen years later . Lupus 1998; 7: 214–222 .

Murakawa Y , Sakane T . Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate . Arthritis Rheum 1988; 31: 826–833 .

Garcia-Cozar FJ et al. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients . Clin Exp Immunol 1996; 104: 72–79 .

Huang YP , Miescher PA , Zubler RH . The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells . J Immunol 1986; 137: 3515–3520 .

Horwitz DA , Wang H , Gray JD . Cytokine gene profile in circulating blood mononuclear cells for patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA . Lupus 1994; 3: 423–428 .

Tsokos GC et al. Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Role of the B7-1 (CD80) costimulatory molecule . Arthritis Rheum 1996; 39: 600–609 .

Mosmann TR . Properties and functions of interleukin-10 . Adv Immunol 1994; 56: 1–26 .

Llorente L et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus . Eur Cytokine Net 1993; 4: 421–430 .

Llorente L et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity . Arthritis Rheum 1994; 37: 1647–1655 .

Houssiau FA et al. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity . Lupus 1995; 4: 393–395 .

Hagiwara E , Gourley MF , Lee S , Klinman DM . Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10 interferon-g-secreting cells in the peripheral blood . Arthritis Rheum 1996; 39: 379–385 .

Llorente L et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus . J Exp Med 1995; 181: 839–844 .

Linker-Israeli M et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis . J Immunol 1991; 147: 117–123 .

Ishida H et al. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice . J Exp Med 1994; 179: 305–310 .

Eskdale J et al. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus . Tissue Antigens 1997; 49: 635–639 .

Lazarus M et al. Genetic variation in the Interleukin-10 gene promoter and systemic lupus erythematosus. J Rheumatol (in press).

Turner DM et al. An investigation of polymorphism in the interleukin-10 gene promoter . Eur J Immunogenet 1997; 24: 1–8 .

Llorente L et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1429–1435 .

Jacob CO , van der Meide PH , McDevitt HO . In vivo treatment of (NZB6NZW)F1 lupus-like nephritis with monoclonal antibody to g interferon . J Exp Med 1987; 166: 798–803 .

Ozmen L et al. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-g receptor inhibits the onset of glomerulonephritis . Eur J Immunol 1995; 25: 6–12 .

Peng SL , Mosleshi J , Craft J . Roles of interferon-g and interleukin-4 in murine lupus . J Clin Invest 1997; 99: 1936–1946 .

Trinchieri G . Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes . Blood 1994; 84: 4008–4027 .

Houssiau FA et al. IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC) . Clin Exp Immunol 1997; 108: 375–380 .

Liu TF , Jones BM . Impairment of IL-12 production in SLE is due to defective monocytes, not B cells . Immunol Lett 1997; 56: 314-314 .

Hagiwara E et al. Beneficial effect of IL-12 gene therapy on the spontaneous autoimmune disease in MRL/lpr mice . Arthritis Rheum 1997; 40: S257-S257 .

Lauwerys B , Renauld J-C , Houssiau FA . Inhibition of in vitro immunoglobulin production by interleukin-12 in murine chronic graft-vs-host disease: synergism with interleukin-18 (submitted for publication).

Ushio S et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein . J Immunol 1996; 156: 4274–4279 .